A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation

被引:15
作者
Depaux, A.
Regnier-Ricard, F.
Germani, A.
Varin-Blank, N.
机构
[1] Univ Paris 05, Inst Cochin, Dept Hematol, CNRS, F-75014 Paris, France
[2] Inserm, U567, Paris, France
关键词
Siah; Pias; ubiquitination; proteasome;
D O I
10.1038/sj.onc.1210486
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein inhibitor of activated STAT ( Pias) and human homologues of seven in absentia ( hSiah) proteins both exhibit properties of ubiquitin- family peptides conjugating enzymes. Pias present E3- ligase activity for small ubiquitin-related modifiers ( Sumo) covalent attachment to their targets. This post- translational modi. cation is responsible for the activation of different transcription factors such as AP1. HSiah proteins possess ubiquitin- E3-ligase activity that triggers their partners to proteasomal-dependent degradation. The present study identifies Pias as a new hSiah2- interacting protein. We demonstrate that hSiah2 regulates specifically the proteasome-dependent degradation of Pias proteins. On reverse, Pias does not prevent hSiah2 degradation. We provide evidences for hSiah2- dependent degradation of Pias as being a mechanism in the regulation of c- jun N- terminal kinase- activating pathways. This report describes a new interconnection between sumoylation and ubiquitination pathways by regulating the levels of the E3-ligases available for these processes.
引用
收藏
页码:6665 / 6676
页数:12
相关论文
共 50 条
  • [21] Androgen receptor-interacting protein 3 and other PIAS proteins cooperate with glucocorticoid receptor-interacting protein 1 in steroid receptor-dependent signaling
    Kotaja, N
    Vihinen, M
    Palvimo, JJ
    Jänne, OA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (20) : 17781 - 17788
  • [22] Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor α degradation
    Lallemand-Breitenbach, V
    Zhu, J
    Puvion, F
    Koken, M
    Honoré, N
    Doubeikovsky, A
    Duprez, E
    Pandolfi, PP
    Puvion, E
    Freemont, P
    de Thé, H
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (12) : 1361 - 1371
  • [23] Induction of apoptosis by protein inhibitor of activated Stat1 through c-jun NH2-terminal kinase activation
    Liu, B
    Shuai, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (39) : 36624 - 36631
  • [24] A transcriptional corepressor of Stat1 with an essential LXXLL signature motif
    Liu, B
    Gross, M
    ten Hoeve, J
    Shuai, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (06) : 3203 - 3207
  • [25] Siah-1 mediates a novel β-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein
    Liu, J
    Stevens, J
    Rote, CA
    Yost, HJ
    Hu, YX
    Neufeld, KL
    White, RL
    Matsunami, N
    [J]. MOLECULAR CELL, 2001, 7 (05) : 927 - 936
  • [26] Ubiquitin ligases and the immuneresponse
    Liu, YC
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 : 81 - 127
  • [27] Liu ZH, 1998, ACTA POLYM SIN, P1
  • [28] Siah-1, SIP, and Ebi collaborate in a novel pathway for β-catenin degradation linked to p53 responses
    Matsuzawa, S
    Reed, JC
    [J]. MOLECULAR CELL, 2001, 7 (05) : 915 - 926
  • [29] Activation of p53 by protein inhibitor of activated Stat1 (PIAS1)
    Megidish, T
    Xu, JH
    Xu, CW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (10) : 8255 - 8259
  • [30] SUMO - Nonclassical ubiquitin
    Melchior, F
    [J]. ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2000, 16 : 591 - +